etiocholanolone has been researched along with strophanthidin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curcic, P; Eaton, DM; Khafaga, M; Knez, I; Kolesnik, E; Köstenberger, M; Lewinski, DV; Pichler, M; Pieske, B; Rainer, PP; Schwantzer, G; Vafiadis, A; Wallner, M | 1 |
1 other study(ies) available for etiocholanolone and strophanthidin
| Article | Year |
|---|---|
Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium.
Topics: Antineoplastic Agents; Cardiotonic Agents; Dose-Response Relationship, Drug; Etiocholanolone; Heart; Heart Atria; Heart Failure; Heart Ventricles; Humans; Strophanthidin | 2017 |